Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

By afschroeder • July 26, 2025

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk JS, Limketkai B. Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn's Disease of the Pouch. Inflamm Bowel Dis. 2025 Jul 25:izaf146. doi: 10.1093/ibd/izaf146. Epub ahead of print. PMID: 40708501.

Tags: CD of the pouch, clinical response, DGSOM Student, Digestive Diseases, durability, endoscopic response, Publications, ustekinumab, vedolizumab

Assessing Treatment Response in Patients With IBS-C in Clinical Practice: Consensus Expert Recommendations Using a Modified Delphi Process

Sayuk GS, Filipenko D, Kornalska K, Swinburn P, Chang L. Assessing Treatment Response in Patients With IBS-C in Clinical Practice: Consensus Expert Recommendations Using a[...]

Hepatic stellate cell subpopulations in human MASLD-related hepatocellular carcinoma upregulate YAP via geranylgeranyl pyrophosphate

Labrecque CL, Ko A, Qiao B, Pan C, Nandakumar R, Chowdhury K, Venkatesan N, Du X, Cai B, Pellegrini M, Pisegna JR, French SW, Agopian[...]

JPEN Journal Club 103. Mixed methods systematic reviews

Koretz RL. JPEN Journal Club 103. Mixed methods systematic reviews. JPEN J Parenter Enteral Nutr. 2026 Aug 15. doi: 10.1002/jpen.70134. Epub ahead of print. PMID:[...]